| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 135, 1877-1886, Copyright © 1994 by Endocrine Society
ARTICLES |
E Wolf, R Kramer, WF Blum, J Foll and G Brem
Lehrstuhl fur Molekulare Tierzucht, Ludwig-Maximilians-Universitat, Munchen, Germany.
Insulin-like growth factor-II (IGF-II) is an important regulator of embryonic growth and differentiation, but its function in postnatal life is unclear. To address this point, we generated transgenic mice harboring fusion genes in which a human IGF-II complementary DNA is placed under the transcriptional control of the rat phosphoenolpyruvate carboxykinase promoter. Transgene-specific messenger RNA was detected in liver, kidney, and several parts of the gut. Serum IGF-II levels in transgenic mice were 2-3 times higher than those in controls and increased after starvation. Circulating IGF-I correlated negatively and IGF-binding protein-2 (IGFBP-2) positively with IGF-II levels, suggesting that IGF-I is displaced from IGFBPs by IGF-II and that IGF- II is a major regulator of IGFBP-2. Serum levels of IGFBP-3 and IGFBP-4 tended to be higher in phosphoenolpyruvate carboxykinase-IGF-II transgenic mice than in controls, as evaluated by ligand blot analysis. Starvation reduced serum IGF-I, but increased IGFBP-2 in transgenic mice more markedly than in controls. Fasting insulin levels were significantly reduced in transgenic mice, whereas glucose levels were not influenced by elevated IGF-II. The body growth of 4- and 12-week- old mice was not significantly influenced by elevated IGF-II, but transgenic mice displayed increased kidney and testis weight at the age of 4 weeks, and increased adrenal weight at the age of 12 weeks. Our results demonstrate that elevated IGF-II in postnatal life has multiple endocrine consequences and subtle time-specific effects on organ growth.
This article has been cited by other articles:
 |
|
 |
|
  M. Bielohuby, N. Herbach, R. Wanke, C. Maser-Gluth, F. Beuschlein, E. Wolf, and A. Hoeflich Growth analysis of the mouse adrenal gland from weaning to adulthood: time- and gender-dependent alterations of cell size and number in the cortical compartment Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E139 - E146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Svensson, A. Tivesten, K. Sjogren, O. Isaksson, G. Bergstrom, S. Mohan, J. Molne, J. Isgaard, and C. Ohlsson Liver-derived IGF-I regulates kidney size, sodium reabsorption, and renal IGF-II expression J. Endocrinol., June 1, 2007; 193(3): 359 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Schmidt, J. M. d. Avila, and D. J. McLean Analysis of Gene Expression in Bovine Testis Tissue Prior to Ectopic Testis Tissue Xenografting and During the Grafting Period Biol Reprod, June 1, 2007; 76(6): 1071 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Moerth, M. R. Schneider, I. Renner-Mueller, A. Blutke, M. W. Elmlinger, R. G. Erben, C. Camacho-Hubner, A. Hoeflich, and E. Wolf Postnatally Elevated Levels of Insulin-Like Growth Factor (IGF)-II Fail to Rescue the Dwarfism of IGF-I-Deficient Mice except Kidney Weight Endocrinology, January 1, 2007; 148(1): 441 - 451. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. V. Gordon, J. B. Paxton, J. F. Kuemmerle, and N. S. Fox A 14-kDa cathepsin L-derived carboxyl IGFBP-2 fragment is sequestered by cultured rat ileal crypt cells Am J Physiol Gastrointest Liver Physiol, July 1, 2005; 289(1): G79 - G87. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Baez-Saldana and E. Ortega Biotin Deficiency Blocks Thymocyte Maturation, Accelerates Thymus Involution, and Decreases Nose-Rump Length in Mice J. Nutr., August 1, 2004; 134(8): 1970 - 1977. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. S. Thorey, B. Hinz, A. Hoeflich, S. Kaesler, P. Bugnon, M. Elmlinger, R. Wanke, E. Wolf, and S. Werner Transgenic Mice Reveal Novel Activities of Growth Hormone in Wound Repair, Angiogenesis, and Myofibroblast Differentiation J. Biol. Chem., June 18, 2004; 279(25): 26674 - 26684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Srivastava, C. Montagna, X. Leighton, M. Glasman, S. Naga, O. Eidelman, T. Ried, and H. B. Pollard Haploinsufficiency of Anx7 tumor suppressor gene and consequent genomic instability promotes tumorigenesis in the Anx7(+/-) mouse PNAS, November 25, 2003; 100(24): 14287 - 14292. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Valet, G. Tavernier, I. Castan-Laurell, J. S. Saulnier-Blache, and D. Langin Understanding adipose tissue development from transgenic animal models J. Lipid Res., June 1, 2002; 43(6): 835 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hoeflich, R. Reisinger, H. Lahm, W. Kiess, W. F. Blum, H. J. Kolb, M. M. Weber, and E. Wolf Insulin-like Growth Factor-binding Protein 2 in Tumorigenesis: Protector or Promoter? Cancer Res., December 1, 2001; 61(24): 8601 - 8610. [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. John, J. F. -X. Ainscough, S. C. Barton, and M. A. Surani Distant cis-elements regulate imprinted expression of the mouse p57 Kip2 (Cdkn1c) gene: implications for the human disorder, Beckwith-Wiedemann syndrome Hum. Mol. Genet., July 1, 2001; 10(15): 1601 - 1609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hoeflich, S. Nedbal, W. F. Blum, M. Erhard, H. Lahm, G. Brem, H. J. Kolb, R. Wanke, and E. Wolf Growth Inhibition in Giant Growth Hormone Transgenic Mice by Overexpression of Insulin-Like Growth Factor-Binding Protein-2 Endocrinology, May 1, 2001; 142(5): 1889 - 1898. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. De la Puente, L. Goya, S. Ramos, M. A. Martin, C. Alvarez, F. Escriva, and A. M. Pascual-Leone Effects of experimental diabetes on renal IGF/IGFBP system during neonatal period in the rat Am J Physiol Renal Physiol, December 1, 2000; 279(6): F1067 - F1076. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. Wood, L. E. Rogler, M. E. Czick, A. G.P. Schuller, and J. E. Pintar Selective Alterations in Organ Sizes in Mice with a Targeted Disruption of the Insulin-Like Growth Factor Binding Protein-2 Gene Mol. Endocrinol., September 1, 2000; 14(9): 1472 - 1482. [Abstract] [Full Text]
|
|
|
|
|
|
M. Holzenberger, P. Leneuve, G. Hamard, B. Ducos, L. Perin, M. Binoux, and Y. Le Bouc A Targeted Partial Invalidation of the Insulin-Like Growth Factor I Receptor Gene in Mice Causes a Postnatal Growth Deficit Endocrinology, July 1, 2000; 141(7): 2557 - 2566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Hernandez Embryo implantation and GnRH antagonists: Embryo implantation: the Rubicon for GnRH antagonists Hum. Reprod., June 1, 2000; 15(6): 1211 - 1216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. SCHNEIDER, H. LAHM, M. WU, A. HOEFLICH, and E. WOLF Transgenic mouse models for studying the functions of insulin-like growth factor-binding proteins FASEB J, April 1, 2000; 14(5): 629 - 640. [Abstract] [Full Text]
|
|
|
|
|
|
A. Hoeflich, M. Wu, S. Mohan, J. Föll, R. Wanke, T. Froehlich, G. J. Arnold, H. Lahm, H. J. Kolb, and E. Wolf Overexpression of Insulin-Like Growth Factor-Binding Protein-2 in Transgenic Mice Reduces Postnatal Body Weight Gain Endocrinology, December 1, 1999; 140(12): 5488 - 5496. [Abstract] [Full Text]
|
|
|
|
|
|
J. J. Smink, J. G. Koster, B. I. Hendriks-Stegeman, and S. C. van Buul-Offers Insulin-Like Growth Factor (IGF) II Induced Changes in Expression of IGF Binding Proteins in Lymphoid Tissues of hIGF-II Transgenic Mice Endocrinology, December 1, 1999; 140(12): 5876 - 5882. [Abstract] [Full Text]
|
|
|
|
|
|
J. Petrik, J. M. Pell, E. Arany, T. J. McDonald, W. L. Dean, W. Reik, and D. J. Hill Overexpression of Insulin-Like Growth Factor-II in Transgenic Mice Is Associated with Pancreatic Islet Cell Hyperplasia Endocrinology, May 1, 1999; 140(5): 2353 - 2363. [Abstract] [Full Text]
|
|
|
|
|
|
M. M. Weber, C. Fottner, P. Schmidt, K. M. H. Brodowski, K. Gittner, H. Lahm, D. Engelhardt, and E. Wolf Postnatal Overexpression of Insulin-Like Growth Factor II in Transgenic Mice Is Associated with Adrenocortical Hyperplasia and Enhanced Steroidogenesis Endocrinology, April 1, 1999; 140(4): 1537 - 1543. [Abstract] [Full Text]
|
|
|
|
|
|
D. J. Drucker, L. Deforest, and P. L. Brubaker Intestinal response to growth factors administered alone or in combination with human [Gly2]glucagon-like peptide 2 Am J Physiol Gastrointest Liver Physiol, December 1, 1997; 273(6): G1252 - G1262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Gnessi, A. Fabbri, and G. Spera Gonadal Peptides as Mediators of Development and Functional Control of the Testis: An Integrated System with Hormones and Local Environment Endocr. Rev., August 1, 1997; 18(4): 541 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Wolf, P. M. Jehle, M. M. Weber, H. Sauerwein, A. Daxenberger, B. H. Breier, U. Besenfelder, L. Frenyo, and G. Brem Human Insulin-Like Growth Factor I (IGF-I) Produced in the Mammary Glands of Transgenic Rabbits: Yield, Receptor Binding, Mitogenic Activity, and Effects on IGF-Binding Proteins Endocrinology, January 1, 1997; 138(1): 307 - 313. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
